Covid and vitamin D: ‘Not enough evidence’ for treatment

People are still advised to take a daily supplement this winter to keep bones and muscles healthy.

Share Button

Potential treatment approach kills lymphoma while sparing healthy cells

Scientists at Scripps Research have demonstrated a promising new strategy for treating lymphomas, a group of cancers that begin in infection-fighting cells of the immune system called lymphocytes.

The new approach uses natural cancer-targeting immune cells, known as natural killer cells, that have been modified to selectively target lymphoma. As described in their study, published in the journal Angewandte Chemie, the modified natural killer cells brought about a dramatic reduction of lymphoma in a mouse.

“We found a way to achieve selectivity in targeting lymphoma cells, which is an important departure from existing therapies,” says co-senior author Peng Wu, PhD, an associate professor in the Department of Molecular Medicine at Scripps Research.

Wu and his lab collaborated in the study with the lab of co-senior author James Paulson, PhD, the Cecil H. and Ida Green Professor and Chair of the Department of Molecular Medicine at Scripps Research.

More than 20,000 people in the United States die of lymphomas annually, while approximately 85,000 people are newly diagnosed. Most lymphomas arise from B cells, an important type of lymphocyte whose primary function is to make antibodies.

Some existing lymphoma treatments, including B-cell-killing antibodies and so-called CAR-T cell therapies, work by targeting B cells indiscriminately, largely wiping them out. However, this strategy brings many adverse side effects, including months of immunosuppression due to low antibody levels.

Wu, Paulson and their teams have developed a more specific approach using natural killer cells, which are immune cells that normally patrol the bloodstream and tissues, seeking and destroying virus-infected or cancerous cells. These immune-system warriors, also known as NK cells, are able to recognize certain tell-tale surface molecules that signify serious damage or malignancy within a cell; they can then kill that target cell through a variety of means, including by secreting proteins that punch holes in the cell’s outer membrane.

Creating a super-powered NK cell

In the early 1990s, Canadian researchers developed a special type of NK cell, NK-92, from a patient with a rare NK-cell cancer. NK-92 cells are relatively easy to grow and multiply in the lab, compared with normal NK cells found in human blood.

The Canadian researchers and others have since shown that NK-92 cells are good at killing different kinds of cancerous cells, and can bring about dramatic results in some patients, with minimal side effects. NK-92MI cells, an easier-to-multiply version of NK-92 cells, are now being widely investigated for use against various cancers.

On their own, NK-92MI cells may not be ideal cancer-fighters, especially not for advanced malignancies, in part because they are dispersed throughout the body when infused into the bloodstream. In the new study, however, Wu and his team used chemistry techniques to modify NK-92MI cells to concentrate their cancer-fighting power against lymphoma.

Steering powerful cells where they’re needed most

In an initial set of experiments, the Scripps Research scientists re-engineered NK-92MI cells to include a surface molecule that binds to a B-cell surface receptor called CD22, which is normally abundant on B-cell-derived lymphoma cells. Thus, in principle, the NK-92MI cells would selectively recognize cancerous B cells.

In cell-culture tests, the modification brought a big improvement in the NK cells’ ability to kill lymphoma cells, and these killer cells did not harm healthy cells. In a mouse model of lymphoma, however, the strategy didn’t work so well, apparently because the NK cells still did not go where they were needed.

“We found that after being injected, these NK cells tend to be found in the lungs and throughout the bloodstream — whereas in this mouse model and in human lymphoma patients, the lymphoma cells are mostly in the bone marrow,” Wu says.

The team then added to their NK cells a new molecule called Sialyl-Lewis X, which made the cells gather in bone marrow amid the lymphoma cells. This led to a dramatic delay in the development of lymphoma in the mice. With this promising result, Wu and his lab now are continuing to develop this and related strategies for clinical use.

Wu and Paulson suspect that in general, adding homing molecules such as Sialyl-Lewis X to cell-based anticancer treatments enhances the cancer-killing power at the site of the cancer, and may be a key to these treatments’ future success — particularly against solid tumors and other highly localized cancers.

Wu notes, too, that Sialyl-Lewis X, which made the NK-92MI cells gather in bone marrow, as well as the CD22-binding molecule that directed the cells to malignant B cells, are both sugar-like “glycan” molecules. Although such molecules are found on virtually all cells, and often have essential biological functions as well as crucial roles in disease, they are difficult to study and thus have been relatively neglected.

“People are only starting to appreciate the importance of glycans,” says Senlian Hong, PhD, the first author of the study and a postdoctoral research associate in the Wu lab at Scripps Research.

Funding was provided by the National Institutes of Health (R01AI143884, R01GM113046, P41GM103390, P01GM107012, R01GM130915, R01AI050143, P01HL107151, U19AI136443) and the Danish National Research Foundation (DNRF107).

Share Button

Experimental vaccine can counter dangerous effects of synthetic cannabinoids

Made in clandestine laboratories and sold widely across the United States, the diverse class of drugs known as synthetic cannabinoids presents a growing public health threat.

In a new study, Scripps Research scientists have devised a way to deactivate these designer drugs after they’ve been administered — offering a potential path for treating addiction and overdose.

The research appears today in the American Chemical Society’s open access journal JACS Au, with findings from the laboratory of Kim Janda, PhD, the Ely R. Callaway, Jr. professor of chemistry at Scripps Research. Janda and his team developed a vaccine that was able to broadly counter the effects of synthetic cannabinoids in rodents, sequestering the drug molecules before they could interact with the central nervous system. Importantly, the approach worked in models that simulated smoking and vaping, which is how the drugs are most commonly used in real life.

“Synthetic cannabinoids are much more powerful and toxic than users often realize, and their rising prevalence has led to serious health issues among young people and adults,” Janda says. “We found a way to negate the dangerous effects of these drugs, even when they’re consumed in impure forms, as is often the case. Our hope is that this may one day help treat cannabinoid use disorders or accelerate recovery for people who overdosed.”

Not to be confused with marijuana

Synthetic cannabinoids act on the same brain cell receptors as THC, the mind-altering ingredient in marijuana. However, they’re human-made in a laboratory, with chemical structures that don’t look anything like THC. Moreover, their actual effects can be unpredictable and, in some cases, fatal, Janda says.

The synthetic drugs are often sprayed on dried plant materials so they can be smoked, or sold as vaping liquids to be inhaled using e-cigarettes. Manufacturers tend to sell the products in colorful foil packages and plastic bottles under a wide variety of brand names, including Spice, K2, Joker, Black Mamba and hundreds of others.

Synthetic cannabinoids are also sometimes mixed with other dangerous drugs such as fentanyl, which can make them more deadly. Overdoses are on the upswing, as evidenced by calls to poison control centers.

“The drugs often called synthetic marijuana are, in reality, very different from marijuana,” the American Association of Poison Control Centers says. “They contain powerful chemicals and can cause severe, life-threatening health effects: severe agitation and anxiety, nausea, vomiting, seizures and hallucinations. The drugs are made specifically to be abused. Like many other illegal drugs, synthetic marijuana is not tested for safety, and users don’t know exactly what chemicals they are putting into their bodies.”

Expanding on a proven method

For the study, Janda says first author Mingliang Lin, a graduate student, wanted to explore whether a vaccine could work against synthetic cannabinoids, just as they have shown to do against some other drugs of abuse. Janda already has developed vaccine-based approaches to combat heroin, fentanyl and cocaine.

As an addiction treatment, Janda believes vaccines provide benefits over other therapeutics, as they don’t require taking a daily pill and can reduce the risk of an overdose if the user relapses.

The newest vaccine differs from Janda’s previous work in that it’s composed of multiple drug-like antigens that stimulate “broadly neutralizing” antibodies within the body, which disable many types of cannabinoids. This is key, as synthetic cannabinoids encompass a wide range of human-made chemicals.

In behavioral experiments involving mice, the team found that even when exposed to a large amount of the drug, the vaccine offered broad protection against the psychoactive effects. The team also developed a version of the vaccine that could be inhaled, which could offer greater convenience.

“This work provides a solid foundation for future therapeutic development against synthetic cannabinoid abuse,” Janda says. “The ultimate goal is to provide prolonged protection for those who may be struggling with substance abuse.”

The study, “Broadly Neutralizing Synthetic Cannabinoid Vaccines,” is authored by Mingliang Lin, Jinny Claire Lee, Steven Blake, Beverly Ellis, Lisa Eubanks and Kim Janda.

The project was supported by the Skaggs Institute for Chemical Biology at Scripps Research.

Share Button

How the spread of the internet is changing migration

The spread of the Internet is shaping migration in profound ways. A McGill-led study of over 150 countries links Internet penetration with migration intentions and behaviours, suggesting that digital connectivity plays a key role in migration decisions and actively supports the migration process.

Countries with higher proportions of Internet users tend to have more people who are willing to emigrate. At the individual level, the association between Internet use and intention to migrate is stronger among women and those with less education. The same result was found for economic migrants compared to political migrants, according to the team of international researchers from McGill University, University of Oxford, University of Calabria, and Bocconi University.

“The digital revolution brought about by the advent of the Internet has transformed our societies, economies, and way of life. Migration is no exception in this revolution,” says co-author Luca Maria Pesando, an Assistant Professor in the Department of Sociology and Centre on Population Dynamics at McGill University.

In the study, published in Population and Development Review, the researchers tracked Internet use and migration pathways with data from the World Bank, the International Telecommunication Union, the Global Peace Index, the Arab Barometer, and the Gallup World Poll, an international survey of citizens across 160 countries.

Their findings underscore the importance of the Internet as an informational channel for migrants who leave their country in search of better opportunities. Unlike political migrants, who might be pushed, for example, by the sudden explosion of a civil conflict, economic migrants’ decisions are more likely to benefit from access to information provided by the Internet, and more likely to be shaped by aspirations of brighter futures in their destination countries.

“The Internet not only gives us access to more information; it allows us to easily compare ourselves to others living in other — often wealthier — countries through social media,” says Pesando.

Case study of Italy

Looking at migration data in Italy — a country that has witnessed sizeable increases in migrant inflows over the past two decades — the researchers found a strong correlation between Internet use in migrants’ countries of origin, and the presence of people from that country in the Italian population register in the following year. Tracking migrants including asylum seekers and refugees passing through the Sant’Anna immigration Centre in Calabria, the researchers also found a link between migrants’ digital skills and knowledge of the Internet and voluntary departure from the Centre in search of better economic opportunities.

“Our findings contribute to the growing research on digital demography, where Internet-generated data or digital breadcrumbs are used to study migration and other demographic phenomena,” says Pesando. “Our work suggests that the Internet acts not just as an instrument to observe migration behaviors, but indeed actively supports the migration process.”

As next steps, the research team, which includes Francesco Billari of Bocconi University and Ridhi Kashyap and Valentina Rotondi of University of Oxford, will explore how digital technology and connectivity affect social development outcomes, ranging from women’s empowerment to reproductive health and children’s wellbeing across generations.

Story Source:

Materials provided by McGill University. Note: Content may be edited for style and length.

Share Button

Thriving Without a God

In your favorite models of reality, do you include a god or gods? Have you tested models and frames that are god-free to see how well they work for you?

I grew up learning models of reality that include a god, in that case a Christian version of one. Later I went atheist, and I enjoyed the godless style of living – perhaps a little too much. It was way more fun, but it took me a few years to find my footing with it.

After that I explored some New Age models that included angels, spirit guides, Source, and so on. There are many flexible ways to include divinity in our models of reality, but one key aspect is whether or not you include any “superior” beings that are more divine than you are.

Here’s what I learned after lots of exploration and experimenting.

Perhaps the most important aspect of these explorations was to learn how mysterious, fascinating, and inherently unknowable so much of reality is. It was a special turning point when I worked through the logic and truly grasped that no matter what kind of entity I am – physical, spiritual, or otherwise – I will never ever be able to discern the true nature of reality. No god would be able to discern that either. It was really interesting to see that even an all-knowing, all-seeing god would never have the power or ability to know what’s outside of its scope.

Even if this god’s scope of knowingness is infinite, you can always put a bigger infinity around it as a container. Even if the god knows everything, there could always be a bigger everything that contains it. And no god could be certain that there wasn’t some other kind of reality beyond its scope.

A smart enough god would eventually figure this out. And it would probably be damned curious to test and probe what kind of reality it exists within, even as it accepts the unknowability of this.

So this helped me see that if there is a god, it’s never actually going to be as omniscient as a religion makes it out to be. And honest god would have to wonder about the extent of its divinity, and hence it would also have to wonder about a lot more than that.

Why does this matter? I grew up being taught a model of reality that included an all-knowing, all-seeing, all-loving god. This model is inconsistent with any sort of reality that includes conscious beings though. So if I do include such a god in my reality, I have to bump it down a few notches in terms of how I relate to it.

If there’s some other conscious entity with superior knowledge and wisdom, that could be interesting, but then I must also recognize that its knowledge and wisdom will always be limited. Since it can’t understand anything beyond the realm of reality that contains it, it can’t even know if parts of me exist beyond its understanding. There are a lot of fundamentals that it can’t know for sure, such as the nature of its power or the true depth and accuracy of its understanding. If such a god cannot access and understand its container reality, it can never really understand itself or anything else within that reality.

Since I’m a part of this god’s reality, this god also can’t actually hope to ever understand my nature, even if it thinks it created me. So an honest god would have to consider me a bit of a mystery too.

Isn’t that interesting? Even the most omniscient god cannot actually hope to understand me completely. Some aspect of my nature will always be opaque and mysterious to it.

You can flip this around as well. In the domains of life where you have the greatest control and deepest understanding, you have to admit that you’ll never reach 100%. There’s always something mysterious and unknowable if you look deeply enough.

You can never know for certain if your base reality is some kind of simulation or not. You can never know if you’re a real biological being or a simulated character with a simulated body. You can never know if your memories are real events or just programmed into you.

Any god you can possibly imagine, as well as any gods that are beyond your imagining, are subject to similar constraints. That’s just the nature of being aware. Awareness has some inherent limits we can’t hope to bypass.

Consequently, I favor the framing that any god, angel, spirit guide, or other entity that may have superior knowledge and wisdom is ultimately just as perplexed about the nature of their reality as I am. I can imagine that they see things from a different perspective, but I can never assume that their perspective is truly superior to my own personal perspective.

Same goes for any human advisors, coaches, teachers, or mentors. No matter how far advanced they may be in some area of life compared to me, I always have to take their advice with a grain of salt. I can never accept their models and understanding as 100% accurate.

One thing I wanted so desperately when I was younger was for someone or something to play the role of my ideal spiritual advisor. I wanted my own personal version of Mr. Miyagi, someone who could give me the most intelligent answers and instructions for getting better results and living a better life. Sometimes I looked for that in the human realm. Sometimes I looked for it in the spiritual realm. But however I searched, I was always disappointed. No such version of god existed, and I eventually accepted that I needed to outgrow this folly.

When I was wallowing in the depths of stuckness, I often turned to spiritual models for answers. I loved reading books about spirituality because they were so comforting. The authors seemed certain of their models, and certainty is such a tempting drug when you’re stuck. Solutions were presented as: Try this and it will always work (if you’re spiritual enough).

Of course their models felt flat when I actually tried to practice them. The results were sometimes fascinating, sometimes dreadful, and generally inconsistent. A special turning point happened when I got into public speaking and realized that behind the scenes, these teachers are just as confused as everyone else, but they’re good at marketing certainty.

Pick anyone on earth that you might label as a spiritual guru. Then consider the framing that they’re really no wiser than you are. They may have good marketing skills though.

Eventually I found that a more effective way to connect with spirituality isn’t by looking for a wiser entity with the answers I need. It’s better to recognize that uncertainty is universal, and no advice should be swallowed whole.

These days I find it more effective to use models of reality that don’t include any superior beings. I don’t need a god or gods to look up to. We’re all essentially on equal footing. No spirit guide or coach has any guaranteed superior perspective to my own, but they may offer different perspectives for me to sample and test.

This year I received much advice that I could easily have put on a pedestal due to where it came from, but then I kept getting better results when instead of acting on the advice blindly, I chewed on it for a bit, let it bounce around in my thoughts and feelings, and then I made my own independent decisions, often doing the opposite of what the advice was. I really liked the results of that.

Consider that the more faith you put in a god (or in any other spiritual being), the more powerless and helpless you become. This may be good marketing for those who want to fill that power void and insert themselves above you, but it’s not good spirituality.

I’ve also witnessed this from the other side. Sometimes when I share coaching insights or advice, the person I’m coaching will apply the ideas very differently than I expected. Or they may reject the advice and do their own thing. The coaching challenges them to go deeper into their own thinking and figure out what’s likely to work for them.

I’ve noticed that a lot of people take effective actions after coaching, but it’s best when they see the coach as a relative equal, not as someone whose advice should be taken blindly. I’ve seen other people follow a coach’s advice blindly when it’s contrary to their own best thinking. Even when the external results look good, they still seem unhappy and unsatisfied. People who seem happiest keep putting their own spin on what they learn.

We seem to get better results when we behave like co-gods who have no superior. Even if you want to include a divine god in your model, I encourage you to see that god as an equal teammate, not as any sort of superior being. At least try that model on for size if you like having a god to play with. Personally I prefer goddesses, but just the human kind.

Be cautious about adopting a model with a divine being that you presume is somehow superior to you. This type of model keeps people stuck in an immature and child-like relationship with reality. I know it can be comforting, but you can still create those feelings of comfort by relating to reality as an equal, not as some kind of lesser or more limited being.

Do we actually need a superior god in our models of reality? No, we don’t. I fail to see any areas where such models provide benefits that other models don’t surpass, unless you just want to go slower and wallow in powerlessness for a while. Maybe that’s an interesting setup experience, so you can later appreciate the contrast with better models, but I don’t recommend you remain stuck there for too long. Feel free to let go of any superior god once you feel that model has run its course for you. Drop the “levels of consciousness” nonsense too; there are no levels.

When someone suggests or demands that you believe in a superior being, look to their own self-interest, and it won’t be too hard to see why they’re promoting such a model.

Imagine living in a reality where you’re inferior to no one. You have no superiors. There are no spiritual entities that are above you in any meaningful way. There are just a lot of different perspectives.

If you still feel clingy with god-based models, just remember that there are alternatives, and you’ll probably want to explore them sooner or later. I think you’ll like being god-free once you get used to it.

Share Button

Ella Adoo-Kissi-Debrah: Air pollution a factor in girl’s death, inquest finds

Ella Adoo-Kissi-Debrah was “living on a knife edge” before her fatal asthma attack, the inquest heard.

Share Button

Covid vaccine: More than 130,000 vaccinated in UK in first week

Health Minister Nadhim Zahawi says it is a “really good start” to the UK’s programme.

Share Button

An avocado a day keeps your gut microbes happy, study shows

Eating avocado as part of your daily diet can help improve gut health, a new study from University of Illinois shows. Avocados are a healthy food that is high in dietary fiber and monounsaturated fat. However, it was not clear how avocados impact the microbes in the gastrointestinal system or “gut.”

“We know eating avocados helps you feel full and reduces blood cholesterol concentration, but we did not know how it influences the gut microbes, and the metabolites the microbes produce,” says Sharon Thompson, graduate student in the Division of Nutritional Sciences at U of I and lead author on the paper, published in the Journal of Nutrition.

The researchers found that people who ate avocado every day as part of a meal had a greater abundance of gut microbes that break down fiber and produce metabolites that support gut health. They also had greater microbial diversity compared to people who did not receive the avocado meals in the study.

“Microbial metabolites are compounds the microbes produce that influence health,” Thompson says. “Avocado consumption reduced bile acids and increased short chain fatty acids. These changes correlate with beneficial health outcomes.”

The study included 163 adults between 25 and 45 years of age with overweight or obesity — defined as a BMI of at least 25 kg/m2 — but otherwise healthy. They received one meal per day to consume as a replacement for either breakfast, lunch, or dinner. One group consumed an avocado with each meal, while the control group consumed a similar meal but without the avocado. The participants provided blood, urine, and fecal samples throughout the 12-week study. They also reported how much of the provided meals they consumed, and every four weeks recorded everything they ate.

While other research on avocado consumption has focused on weight loss, participants in this study were not advised to restrict or change what they ate. Instead they consumed their normal diets with the exception of replacing one meal per day with the meal the researchers provided.

The purpose of this study was to explore the effects of avocado consumption on the gastrointestinal microbiota, says Hannah Holscher, assistant professor of nutrition in the Department of Food Science and Human Nutrition at U of I and senior author of the study.

“Our goal was to test the hypothesis that the fats and the fiber in avocados positively affect the gut microbiota. We also wanted to explore the relationships between gut microbes and health outcomes,” Holscher says.

Avocados are rich in fat; however, the researchers found that while the avocado group consumed slightly more calories than the control group, slightly more fat was excreted in their stool.

“Greater fat excretion means the research participants were absorbing less energy from the foods that they were eating. This was likely because of reductions in bile acids, which are molecules our digestion system secretes that allow us to absorb fat. We found that the amount of bile acids in stool was lower and the amount of fat in the stool was higher in the avocado group,” Holscher explains.

Different types of fats have differential effects on the microbiome. The fats in avocados are monounsaturated, which are heart-healthy fats.

Soluble fiber content is also very important, Holscher notes. A medium avocado provides around 12 grams of fiber, which goes a long way toward meeting the recommended amount of 28 to 34 grams of fiber per day.

“Less than 5% of Americans eat enough fiber. Most people consume around 12 to 16 grams of fiber per day. Thus, incorporating avocados in your diet can help get you closer to meeting the fiber recommendation,” she notes.

Eating fiber isn’t just good for us; it’s important for the microbiome, too, Holscher states. “We can’t break down dietary fibers, but certain gut microbes can. When we consume dietary fiber, it’s a win-win for gut microbes and for us.”

Holscher’s research lab specializes in dietary modulation of the microbiome and its connections to health. “Just like we think about heart-healthy meals, we need to also be thinking about gut healthy meals and how to feed the microbiota,” she explains.

Avocado is an energy-dense food, but it is also nutrient dense, and it contains important micronutrients that Americans don’t eat enough of, like potassium and fiber.

“It’s just a really nicely packaged fruit that contains nutrients that are important for health. Our work shows we can add benefits to gut health to that list,” Holscher says.

The paper, “Avocado consumption alters gastrointestinal bacteria abundance and microbial metabolite concentrations among adults with overweight or obesity: a randomized controlled trial” is published in the Journal of Nutrition.

Authors are Sharon Thompson, Melisa Bailey, Andrew Taylor, Jennifer Kaczmarek, Annemarie Mysonhimer, Caitlyn Edwards, Ginger Reeser, Nicholas Burd, Naiman Khan, and Hannah Holscher.

Funding for the research was provided by the Hass Avocado Board and the USDA National Institute of Food and Agriculture, Hatch project 1009249. Sharon Thompson was supported by the USDA National Institute of Food and Agriculture AFRI Predoctoral Fellowship, project 2018-07785, and the Illinois College of ACES Jonathan Baldwin Turner Fellowship. Jennifer Kaczmarek was supported by a Division of Nutrition Sciences Excellence Fellowship. Andrew Taylor was supported by a Department of Food Science and Human Nutrition Fellowship. The Division of Nutritional Sciences provided seed funding through the Margin of Excellence endowment.

The Division of Nutritional Sciences and the Department of Food Science and Human Nutrition are in the College of Agricultural, Consumer and Environmental Sciences, University of Illinois.

Share Button

Researchers turn DNA detectives to aid rhino poaching prosecutions with forensic evidence

The project is part of the Rhino DNA Indexing System (RhODIS- India) conservation program. This database has been created to build a DNA catalogue of the existing Indian greater one-horned rhinoceros, Rhinoceros unicornis, to tackle rhino poaching and assist conservation efforts for this vulnerable species.

Inspired by a similar program in South Africa, PhD student and senior research fellow Tista Ghosh, along with Dr Samrat Mondol (WII) and Amit Sharma (WWF India), collected dung from 749 rhinoceros to gather vital genetic information. By analysing dung for traces of population specific genetic signals, a genetic baseline was created for rhinoceros across India and 406 unique individuals were identified.

Microsatellite markers are present in nuclear DNA, similar to a fingerprint, where each individual has its own unique genetic signature. The use of 14 markers helps to identify individuals from dung data based on unique individual rhino’s signature.

By comparing seized rhino horn samples to these specific genetic signals, the researchers could trace the rhino back to its breeding population, thus identifying trade routes and pinpointing poaching hotspots, which are notoriously difficult for traditional law enforcement to track.

“Having an allele frequency map aids in pinpointing the location of the orphan seized rhino sample to its breeding population based on genetic signatures,” commented Tista Ghosh.

The forensics team at WII were also able to match a suspected poached carcass from a protected area to a seized horn found elsewhere along the trade route in India. Occasionally, they had as little to work with as blood-stained soil, pebbles or a bullet to perform DNA profiling.

These results display the powerful abilities which this microsatellite panel has for tackling wildlife crime and providing valuable insights to the forest department. Furthermore, individual DNA matching assists in court prosecutions by providing concrete scientific evidence regarding the poaching of wild rhino, native to India.

On the significance of this method, Tista said: “Many times the seized rhino body parts are found after a long time of poaching incidence as a result of which it becomes difficult to pinpoint the location of the crime. Thus, it is important to locate such networks and have law enforcement resulting in breaking the chain of trading.”

India’s current population of greater one-horned rhinoceros’ is relatively small, at approximately 3,500 rhino individuals. Using statistical probabilities, the team calculated that 14 microsatellite markers were sufficient to be able to do individual matching across the whole range of the population.

In addition, the researchers are keen to collaborate with Nepal field teams to extend this work to the second strong hold of greater one-horned rhinoceros.

However, in the field of wildlife forensics, there are severe limitations due to the poor quality of samples, and circumstances when data could not be generated using microsatellite only. In those scenarios Tista said, of these exciting developments, “We are planning to do a mitochondrial DNA screening to look for park/state specific genetic markers and combine that data with our existing database to avoid such situations.”

Further the RhODIS-India marker panel is still in the process of developing an ‘allelic ladder’ (reference point) for comparisons with other laboratories. When this becomes available, this will foster greater collaboration between the global wildlife forensics community. In order to increase the size of the database, plans are already in place to carry out wider sampling across the Indian rhino’s range.

Tista Ghosh’s talk will be available on-demand from the 14th — 18th of December 2020 at the Festival of Ecology. The selection procedure of a 14-microsatellite panel and its application in curbing rhino poaching in India is currently under review in a peer reviewed scientific journal. This online conference will bring together 1,400 ecologists from than 50 countries to discuss the most recent breakthroughs in ecology.

This research is managed by the Wildlife Institute of India is led by the MOEFC&C (environment ministry) in India in collaboration with WWF India and the Wildlife Institute of India.

Share Button

Immune cell that drives breast cancer could be effective target in novel immunotherapies

Breast cancer is the most common cancer in women worldwide, but many immunotherapies have had limited success in treating aggressive forms of the disease.

“A deeper understanding of the immunobiology of breast cancer is critical to the success in harnessing immunotherapeutic approaches to improve breast cancer survival,” said Paula Bos, Ph.D., member of the Cancer Biology research program at VCU Massey Cancer Center and assistant professor in the Department of Pathology at the VCU School of Medicine.

New research findings from Bos, published in Cell Reports, identified a type of immune cells that acts as a major driver of breast cancer growth by preventing the accumulation of a specific protein that induces anti-tumor responses. This new knowledge could be utilized for the development of novel immunotherapeutic approaches to treat the disease.

Regulatory T cells (Treg cells) are a special class of immune cells that possess a unique ability to suppress the function of other immune cells. This function serves to protect the organism from overreacting to certain molecules created within the body; however, in many cases it subdues the immune system’s ability to attack cancer cells. Therefore, Treg cells are often abundant in solid tumors, particularly breast cancers, and are commonly associated with worse outcomes.

In previous research, Bos demonstrated that targeting Treg cells in breast cancer models significantly reduced tumor growth and metastasis; however, it remained unclear on a molecular level why this tumor reduction was happening.

There is a specific protein called interferon gamma (IFN-g) that has powerful anti-tumor properties, including the activation of macrophages, which are cells that can initiate inflammation and prevent cancer growth.

Bos’ latest study suggests that Treg cells suppress IFN-g production by CD4 T lymphocytes (a type of white blood cells), further instigating disease progression. After analyzing breast cancer models in which Treg cells had been targeted and destroyed, Bos discovered an increased presence of IFN-g and functional reprogramming of macrophages into tumor-fighting cells.

“Additionally, we demonstrated better overall survival in human cancers with similar genetic patterns to those observed in mice with breast cancer whose Treg cells were eliminated,” Bos said.

This research is the first of its kind to study the mechanistic function of Treg cells in breast cancer.

Bos said these findings validate the potential for adoptive transfer therapeutics using macrophages programmed with the IFN-g protein to effectively treat breast cancer. Adoptive transfer refers to the process of transferring external cells into a patient to improve immune function or response.

“Our work raises the possibility that white blood cells can be extracted from cancer patients, reprogrammed outside of their body through brief exposure to the IFN-g protein and re-infused back into the patient, contributing to the generation of anti-tumor responses,” Bos said.

Bos is currently studying the function of Treg cells in metastatic cancer and plans to design follow-up studies testing the utilization of IFN-g as an adoptive transfer therapeutic agent in cancer mouse models.

Bos collaborated on this research with Mikhail Dozmorov, Ph.D., member of the Cancer Biology research program at Massey; Amy Olex, M.S., of the VCU C. Kenneth and Dianne Wright Center for Clinical and Translational Research; and Nicholas Clark, Ph.D., James deLigio, Comfort Effi, Leandro Martinez, and Steven Murdock of the VCU School of Medicine.

Story Source:

Materials provided by Virginia Commonwealth University. Original written by Blake Belden. Note: Content may be edited for style and length.

Share Button